CYTK
Price
$56.68
Change
+$0.97 (+1.74%)
Updated
Oct 4 closing price
25 days until earnings call
XBIT
Price
$7.48
Change
+$0.43 (+6.10%)
Updated
Oct 4 closing price
32 days until earnings call
Ad is loading...

CYTK vs XBIT

Header iconCYTK vs XBIT Comparison
Open Charts CYTK vs XBITBanner chart's image
Cytokinetics
Price$56.68
Change+$0.97 (+1.74%)
Volume$1.19M
CapitalizationN/A
XBiotech
Price$7.48
Change+$0.43 (+6.10%)
Volume$19.29K
CapitalizationN/A
View a ticker or compare two or three
CYTK vs XBIT Comparison Chart
Loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
XBIT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
CYTK vs. XBIT commentary
Oct 06, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a StrongBuy and XBIT is a StrongBuy.

COMPARISON
Comparison
Oct 06, 2024
Stock price -- (CYTK: $56.68 vs. XBIT: $7.48)
Brand notoriety: CYTK and XBIT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 93% vs. XBIT: 37%
Market capitalization -- CYTK: $6.16B vs. XBIT: $235.48M
CYTK [@Biotechnology] is valued at $6.16B. XBIT’s [@Biotechnology] market capitalization is $235.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 1 FA rating(s) are green whileXBIT’s FA Score has 1 green FA rating(s).

  • CYTK’s FA Score: 1 green, 4 red.
  • XBIT’s FA Score: 1 green, 4 red.
According to our system of comparison, CYTK is a better buy in the long-term than XBIT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 5 TA indicator(s) are bullish while XBIT’s TA Score has 6 bullish TA indicator(s).

  • CYTK’s TA Score: 5 bullish, 4 bearish.
  • XBIT’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, both CYTK and XBIT are a good buy in the short-term.

Price Growth

CYTK (@Biotechnology) experienced а +8.29% price change this week, while XBIT (@Biotechnology) price change was +3.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.46%. For the same industry, the average monthly price growth was +1.89%, and the average quarterly price growth was -5.77%.

Reported Earning Dates

CYTK is expected to report earnings on Feb 20, 2025.

XBIT is expected to report earnings on Nov 07, 2024.

Industries' Descriptions

@Biotechnology (+1.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($6.16B) has a higher market cap than XBIT($235M). XBIT YTD gains are higher at: 87.000 vs. CYTK (-32.112). XBIT has higher annual earnings (EBITDA): -41.19M vs. CYTK (-459.67M). CYTK has more cash in the bank: 1.06B vs. XBIT (189M). XBIT has less debt than CYTK: XBIT (10M) vs CYTK (790M). CYTK has higher revenues than XBIT: CYTK (3.13M) vs XBIT (0).
CYTKXBITCYTK / XBIT
Capitalization6.16B235M2,620%
EBITDA-459.67M-41.19M1,116%
Gain YTD-32.11287.000-37%
P/E RatioN/AN/A-
Revenue3.13M0-
Total Cash1.06B189M559%
Total Debt790M10M7,900%
FUNDAMENTALS RATINGS
CYTK vs XBIT: Fundamental Ratings
CYTK
XBIT
OUTLOOK RATING
1..100
1026
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
76
Overvalued
PROFIT vs RISK RATING
1..100
43100
SMR RATING
1..100
10094
PRICE GROWTH RATING
1..100
4638
P/E GROWTH RATING
1..100
19
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XBIT's Valuation (76) in the Biotechnology industry is in the same range as CYTK (100). This means that XBIT’s stock grew similarly to CYTK’s over the last 12 months.

CYTK's Profit vs Risk Rating (43) in the Biotechnology industry is somewhat better than the same rating for XBIT (100). This means that CYTK’s stock grew somewhat faster than XBIT’s over the last 12 months.

XBIT's SMR Rating (94) in the Biotechnology industry is in the same range as CYTK (100). This means that XBIT’s stock grew similarly to CYTK’s over the last 12 months.

XBIT's Price Growth Rating (38) in the Biotechnology industry is in the same range as CYTK (46). This means that XBIT’s stock grew similarly to CYTK’s over the last 12 months.

CYTK's P/E Growth Rating (1) in the Biotechnology industry is in the same range as XBIT (9). This means that CYTK’s stock grew similarly to XBIT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CYTKXBIT
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
78%
Momentum
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
70%
MACD
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
74%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 7 days ago
71%
Declines
ODDS (%)
Bearish Trend 10 days ago
75%
Bearish Trend 12 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
85%
View a ticker or compare two or three
Ad is loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
XBIT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CWEB57.033.46
+6.46%
Direxion Dly CSI CHN Itnet Bull 2X Shrs
PXJ30.810.29
+0.97%
Invesco Oil & Gas Services ETF
VTHR253.652.32
+0.92%
Vanguard Russell 3000 ETF
SNPV32.130.21
+0.65%
Xtrackers S&P 500 Value ESG ETF
JXI70.25-0.30
-0.43%
iShares Global Utilities ETF

CYTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYTK has been loosely correlated with VBIVQ. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTK jumps, then VBIVQ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTK
1D Price
Change %
CYTK100%
+1.74%
VBIVQ - CYTK
44%
Loosely correlated
-44.86%
KRON - CYTK
43%
Loosely correlated
+3.36%
IOVA - CYTK
42%
Loosely correlated
+7.17%
DARE - CYTK
42%
Loosely correlated
+1.55%
CKPT - CYTK
41%
Loosely correlated
+1.83%
More

XBIT and

Correlation & Price change

A.I.dvisor indicates that over the last year, XBIT has been loosely correlated with ORMP. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if XBIT jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XBIT
1D Price
Change %
XBIT100%
+6.10%
ORMP - XBIT
36%
Loosely correlated
-2.49%
AXON - XBIT
34%
Loosely correlated
+1.63%
VBIVQ - XBIT
32%
Poorly correlated
-44.86%
GOSS - XBIT
31%
Poorly correlated
+5.94%
CYTK - XBIT
31%
Poorly correlated
+1.74%
More